618 related articles for article (PubMed ID: 21712672)
1. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
O'Carroll CB; Capampangan DJ; Aguilar MI; Bravo TP; Hoffman-Snyder CR; Wingerchuk DM; Wellik KE; Demaerschalk BM
Neurologist; 2011 Jul; 17(4):232-5. PubMed ID: 21712672
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
Strom RG; Frempong-Boadu AK
Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
[TBL] [Abstract][Full Text] [Related]
3. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.
Kiphuth IC; Staykov D; Köhrmann M; Struffert T; Richter G; Bardutzky J; Kollmar R; Mäurer M; Schellinger PD; Hilz MJ; Doerfler A; Schwab S; Huttner HB
Cerebrovasc Dis; 2009; 27(2):146-50. PubMed ID: 19039218
[TBL] [Abstract][Full Text] [Related]
4. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage.
Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H
Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711
[TBL] [Abstract][Full Text] [Related]
5. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
7. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
8. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
10. Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study.
Qian C; Huhtakangas J; Juvela S; Bode MK; Tatlisumak T; Savolainen M; Numminen H; Ollikainen J; Luostarinen L; Kupila L; Tetri S
Clin Neurol Neurosurg; 2021 Mar; 202():106534. PubMed ID: 33578226
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
14. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
[TBL] [Abstract][Full Text] [Related]
17. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.
Davidson BL
Haemostasis; 2000; 30 Suppl 2():77-81; discussion 63. PubMed ID: 11251346
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.
Nurmohamed MT; van Riel AM; Henkens CM; Koopman MM; Que GT; d'Azemar P; Büller HR; ten Cate JW; Hoek JA; van der Meer J; van der Heul C; Turpie AG; Haley S; Sicurella A; Gent M
Thromb Haemost; 1996 Feb; 75(2):233-8. PubMed ID: 8815566
[TBL] [Abstract][Full Text] [Related]
20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
